annual CFI:
-$574.82M-$374.40M(-186.82%)Summary
- As of today (June 28, 2025), CRNX annual cash flow from investing activities is -$574.82 million, with the most recent change of -$374.40 million (-186.82%) on December 31, 2024.
- During the last 3 years, CRNX annual CFI has fallen by -$518.33 million (-917.68%).
- CRNX annual CFI is now -1479.55% below its all-time high of $41.67 million, reached on December 31, 2019.
Performance
CRNX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$85.96M+$456.13M(+84.14%)Summary
- As of today (June 28, 2025), CRNX quarterly cash flow from investing activities is -$85.96 million, with the most recent change of +$456.13 million (+84.14%) on March 31, 2025.
- Over the past year, CRNX quarterly CFI has dropped by -$86.27 million (-27919.09%).
- CRNX quarterly CFI is now -276.31% below its all-time high of $48.76 million, reached on March 31, 2023.
Performance
CRNX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$661.09M-$86.27M(-15.01%)Summary
- As of today (June 28, 2025), CRNX TTM cash flow from investing activities is -$661.09 million, with the most recent change of -$86.27 million (-15.01%) on March 31, 2025.
- Over the past year, CRNX TTM CFI has dropped by -$412.23 million (-165.65%).
- CRNX TTM CFI is now -633.71% below its all-time high of $123.87 million, reached on June 30, 2023.
Performance
CRNX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CRNX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -186.8% | -10000.0% | -165.7% |
| 3 y3 years | -917.7% | -98.1% | -399.4% |
| 5 y5 years | -1479.5% | -626.1% | -2078.9% |
CRNX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -917.7% | at low | -276.3% | +84.1% | -633.7% | at low |
| 5 y | 5-year | -1479.5% | at low | -276.3% | +84.1% | -633.7% | at low |
| alltime | all time | -1479.5% | at low | -276.3% | +84.1% | -633.7% | at low |
CRNX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$85.96M(-84.1%) | -$661.09M(+15.0%) |
| Dec 2024 | -$574.82M(+186.8%) | -$542.09M(-2731.1%) | -$574.82M(+378.9%) |
| Sep 2024 | - | $20.60M(-138.4%) | -$120.04M(-64.1%) |
| Jun 2024 | - | -$53.64M(<-9900.0%) | -$333.94M(+34.2%) |
| Mar 2024 | - | $309.00K(-100.4%) | -$248.86M(+24.2%) |
| Dec 2023 | -$200.41M(+15.2%) | -$87.31M(-54.8%) | -$200.41M(+162.8%) |
| Sep 2023 | - | -$193.30M(-714.9%) | -$76.25M(-161.6%) |
| Jun 2023 | - | $31.44M(-35.5%) | $123.87M(-251.3%) |
| Mar 2023 | - | $48.76M(+32.3%) | -$81.84M(-53.0%) |
| Dec 2022 | -$173.98M(+208.0%) | $36.85M(+440.2%) | -$173.98M(-44.3%) |
| Sep 2022 | - | $6.82M(-103.9%) | -$312.63M(-4.2%) |
| Jun 2022 | - | -$174.27M(+301.7%) | -$326.48M(+146.6%) |
| Mar 2022 | - | -$43.38M(-57.4%) | -$132.37M(+134.4%) |
| Dec 2021 | -$56.48M(<-9900.0%) | -$101.80M(+1349.1%) | -$56.48M(-255.1%) |
| Sep 2021 | - | -$7.03M(-135.4%) | $36.42M(+95.7%) |
| Jun 2021 | - | $19.84M(-39.0%) | $18.62M(+13.7%) |
| Mar 2021 | - | $32.50M(-465.5%) | $16.38M(+7448.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $217.00K(-99.5%) | -$8.89M(-64.2%) | $217.00K(-105.8%) |
| Sep 2020 | - | -$24.83M(-241.1%) | -$3.71M(-108.9%) |
| Jun 2020 | - | $17.60M(+7.7%) | $41.57M(+24.4%) |
| Mar 2020 | - | $16.34M(-227.4%) | $33.41M(-19.8%) |
| Dec 2019 | $41.67M(-134.9%) | -$12.82M(-162.7%) | $41.67M(-164.9%) |
| Sep 2019 | - | $20.45M(+116.5%) | -$64.19M(-24.4%) |
| Jun 2019 | - | $9.44M(-61.6%) | -$84.89M(-10.5%) |
| Mar 2019 | - | $24.60M(-120.7%) | -$94.80M(-20.6%) |
| Dec 2018 | -$119.46M(>+9900.0%) | -$118.68M(>+9900.0%) | -$119.46M(>+9900.0%) |
| Sep 2018 | - | -$251.00K(-46.5%) | -$1.01M(+30.1%) |
| Jun 2018 | - | -$469.00K(+722.8%) | -$775.00K(+127.3%) |
| Mar 2018 | - | -$57.00K(-75.3%) | -$341.00K(+12.2%) |
| Dec 2017 | -$304.00K(+60.0%) | -$231.00K(+1183.3%) | -$304.00K(+316.4%) |
| Sep 2017 | - | -$18.00K(-48.6%) | -$73.00K(+32.7%) |
| Jun 2017 | - | -$35.00K(+75.0%) | -$55.00K(+175.0%) |
| Mar 2017 | - | -$20.00K | -$20.00K |
| Dec 2016 | -$190.00K | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual CFI year-on-year change?
- What is Crinetics Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly CFI year-on-year change?
- What is Crinetics Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM CFI year-on-year change?
What is Crinetics Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of CRNX is -$574.82M
What is the all time high annual CFI for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual cash flow from investing activities is $41.67M
What is Crinetics Pharmaceuticals annual CFI year-on-year change?
Over the past year, CRNX annual cash flow from investing activities has changed by -$374.40M (-186.82%)
What is Crinetics Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of CRNX is -$85.96M
What is the all time high quarterly CFI for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly cash flow from investing activities is $48.76M
What is Crinetics Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, CRNX quarterly cash flow from investing activities has changed by -$86.27M (-27919.09%)
What is Crinetics Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of CRNX is -$661.09M
What is the all time high TTM CFI for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM cash flow from investing activities is $123.87M
What is Crinetics Pharmaceuticals TTM CFI year-on-year change?
Over the past year, CRNX TTM cash flow from investing activities has changed by -$412.23M (-165.65%)